蹭热点难逃法网，英集芯误导陈述遭立案

Group 1 - The company, Yingjixin, claimed on January 6, 2026, that its chip is designed for measuring human bioelectric signals, has been mass-produced, and performs comparably to leading overseas products, which led to significant market excitement and stock price volatility [1][4] - Following regulatory scrutiny, the company admitted the chip is primarily for "non-invasive" applications, fundamentally differing from the mainstream "invasive" technologies, and clarified that the product is still in the market cultivation phase with no significant contribution to current performance [4][5] - The company's misleading statements prompted the China Securities Regulatory Commission (CSRC) to issue a formal investigation notice on February 14, 2026, indicating potential violations of information disclosure principles by manipulating Q&A sessions to attract investors [2][5] Group 2 - Investors who purchased shares between January 6, 2026, and February 13, 2026, and sold or still hold shares after February 14, 2026, may be eligible for compensation due to losses incurred from the company's misleading disclosures [2][5] - The company is under investigation for serious breaches of the principle of truthful, accurate, and complete information disclosure, highlighting the importance of maintaining integrity in corporate communications [5]